Massachusetts S 2520: An Act relative to pharmaceutical access, costs and transparency

Status: Reported by S3012 (as of 2024-12-30)

State: Massachusetts · Session: 193rd · Bill: S 2520

Sponsors: Senate Committee on Bills in the Third Reading, Angelo L. D'Emilia, Bradley H. Jones, Jr., Bruce E. Tarr, Carmine Lawrence Gentile, Carole A. Fiola, Christopher Hendricks, Cindy F. Friedman, Edward F. Coppinger, F. Jay Barrows, Jack Patrick Lewis, James B. Eldridge, Jason M. Lewis, Joanne M. Comerford, John J. Lawn, Jr., Joint Committee on Health Care Financing, Josh S. Cutler, Julian Cyr, Kate Hogan, Kimberly N. Ferguson, Lindsay N. Sabadosa, Marcus S. Vaughn, Michael J. Finn, Michael O. Moore, Mindy Domb

View Massachusetts S 2520 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.